New Variants. New Boosters. But So Far, No New COVID Spending From Congress
Consider This from NPR
00:00
Intro
This chapter discusses the emergence of the new COVID sub-variant BA2 in the U.S. and the implications for infection rates and vaccination efforts. It emphasizes the urgency for congressional funding to address the public health challenges posed by the variant amid concerns about waning immunity.
Play episode from 00:00
Transcript
